Life Sciences Greenhouse of Pennsylvania
Venture Capital
Active
Harrisburg, United States
18
4M
12
0.86
6
0.33
- Stages of investment
- Areas of investment
Summary
In 2002 was created Life Sciences Greenhouse of Pennsylvania, which is appeared as Corporate Investor. The fund was located in North America if to be more exact in United States. The main department of described Corporate Investor is located in the Harrisburg.
The fund has exact preference in some founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. Among the most popular portfolio startups of the fund, we may highlight NanoHorizons, Immunomic Therapeutics, Novasentis. We can highlight the next thriving fund investment areas, such as Wearables, Software. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States.
The common things for fund are deals in the range of 5 - 10 millions dollars. The real fund results show that this Corporate Investor is 26 percentage points more often commits exit comparing to other companies. The fund is constantly included in less than 2 deals per year. The high activity for fund was in 2006.
The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Life Sciences Greenhouse of Pennsylvania, startups are often financed by Roche Venture Fund, Berwind Private Equity, Ben Franklin Technology Partners of Northeastern Pennsylvania. The meaningful sponsors for the fund in investment in the same round are Roche Venture Fund, Berwind Private Equity, Fisk Ventures. In the next rounds fund is usually obtained by Roche Venture Fund, Originate Ventures, Fisk Ventures.
Investor highlights
- Industry focus
- Stage focus
- Geo focus
- Check size
- 250K — 500K
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 18
- Lead investments
- 6
- Rounds per year
- 0.86
- Follow on index
- 0.33
- Investments by industry
- Biotechnology (9)
- Health Care (9)
- Medical Device (7)
- Therapeutics (7)
- Software (6) Show 11 more
- Investments by region
-
- United States (18)
- Peak activity year
- 2006
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 16
- Group Appearance index
- 0.50
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Avisi Technologies | 01 Oct 2023 | Health Care, Medical Device, Nanotechnology | Seed | 6M | United States, Pennsylvania, Philadelphia |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.